iSpecimen Inc.
General ticker "ISPC" information:
- Sector: Health Care
- Industry: Health Care Technology
- Capitalization: $931.1K (TTM average)
iSpecimen Inc. does not follow the US Stock Market performance with the rate: -12.0%.
Estimated limits based on current volatility of 8.5%: low 0.42$, high 0.49$
Factors to consider:
- Total employees count: 53 (-29.3%) as of 2023
- Top business risk factors: Technology failures, Geopolitical risks, Market competition, Customer retention, Recruitment issues
- Current price 76.2% below estimated low
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [2.04$, 6.93$]
- 2025-12-31 to 2026-12-31 estimated range: [1.89$, 6.30$]
Financial Metrics affecting the ISPC estimates:
- Positive: with PPE of -0.2 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -392.59 <= 0.33
- Negative: negative Industry operating cash flow (median)
- Positive: Inventory ratio change, % of 0.28 <= 0.84
- Positive: Industry inventory ratio change (median), % of -0.79 <= -0.15
- Positive: 18.93 < Shareholder equity ratio, % of 35.41 <= 41.86
Short-term ISPC quotes
Long-term ISPC plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $10.40MM | $9.93MM | $9.29MM |
| Operating Expenses | $20.59MM | $21.10MM | $22.02MM |
| Operating Income | $-10.19MM | $-11.17MM | $-12.73MM |
| Non-Operating Income | $-0.06MM | $0.07MM | $0.23MM |
| Interest Expense | $0.24MM | $0.02MM | $0.22MM |
| R&D Expense | $0.00MM | $0.00MM | $3.53MM |
| Income(Loss) | $-10.25MM | $-11.10MM | $-12.50MM |
| Profit(Loss)* | $-9.04MM | $-11.10MM | $-12.50MM |
| Stockholders Equity | $20.31MM | $9.74MM | $3.31MM |
| Assets | $24.62MM | $15.82MM | $9.35MM |
| Operating Cash Flow | $-5.82MM | $-5.81MM | $-8.26MM |
| Capital expenditure | $3.19MM | $4.74MM | $0.06MM |
| Investing Cash Flow | $-3.19MM | $-7.23MM | $1.98MM |
| Financing Cash Flow | $-3.42MM | $0.07MM | $5.82MM |
| Earnings Per Share** | $-20.47 | $-24.55 | $-17.58 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.